{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:44:05Z","timestamp":1761860645838,"version":"build-2065373602"},"reference-count":35,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Sanofi-Aventis (Shanghai, China)"},{"name":"Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      To compare glucose control and safety of different basal insulin therapies (\n                      <jats:styled-content style=\"fixed-case\">BI<\/jats:styled-content>\n                      , including\n                      <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                      nsulin\n                      <jats:styled-content style=\"fixed-case\">NPH<\/jats:styled-content>\n                      , glargine and detemir) in real\u2010world clinical settings based on a large\u2010scale registry study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this multi\u2010center 6\u2010month prospective observational study, patients with type 2 diabetes (\n                      <jats:styled-content style=\"fixed-case\">HbA1c<\/jats:styled-content>\n                      \u2009\u2265\u20097%) who were uncontrolled by oral anti\u2010diabetic drugs (\n                      <jats:styled-content style=\"fixed-case\">OADs<\/jats:styled-content>\n                      ) and were willing to initiate\n                      <jats:styled-content style=\"fixed-case\">BI<\/jats:styled-content>\n                      therapy were enrolled from 209 hospitals within 8 regions of\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      hina. Type and dose of\n                      <jats:styled-content style=\"fixed-case\">BI<\/jats:styled-content>\n                      were at the physician's discretion and the patients\u2019 willingness. Interviews were conducted at 0\u2009months (visit 1), 3\u2009months (visit 2) and 6\u2009months (visit 3). Outcomes included change in\n                      <jats:styled-content style=\"fixed-case\">HbA1c<\/jats:styled-content>\n                      , hypoglycemia rate and body weight from baseline at 6\u2009months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 16\u2009341 and 9002 subjects were involved in\n                      <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                      ntention\u2010\n                      <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                      o\u2010\n                      <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                      reat (\n                      <jats:styled-content style=\"fixed-case\">ITT<\/jats:styled-content>\n                      ) and per\u2010protocol (\n                      <jats:styled-content style=\"fixed-case\">PP<\/jats:styled-content>\n                      ) analysis, respectively. After\n                      <jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>\n                      regression adjustment,\n                      <jats:styled-content style=\"fixed-case\">ITT<\/jats:styled-content>\n                      analysis showed that reduction in\n                      <jats:styled-content style=\"fixed-case\">HbA1c<\/jats:styled-content>\n                      in glargine (2.2%\u2009\u00b1\u20092.1%) and detemir groups (2.2%\u2009\u00b1\u20092.1%) was higher than that in the\n                      <jats:styled-content style=\"fixed-case\">NPH<\/jats:styled-content>\n                      group (2.0%\u2009\u00b1\u20092.2%) (\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                      <\/jats:italic>\n                      \u2009&lt;\u2009.01). The detemir group had the lowest weight gain (\u22120.1\u2009\u00b1\u20092.9\u2009kg) compared with the glargine (+0.1\u2009\u00b1\u20093.0\u2009kg) and\n                      <jats:styled-content style=\"fixed-case\">NPH<\/jats:styled-content>\n                      (+0.3\u2009\u00b1\u20093.1\u2009kg) groups (\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                      <\/jats:italic>\n                      \u2009&lt;\u2009.05). The glargine group had the lowest rate of minor hypoglycaemia, while there was no difference in severe hypoglycaemia among the 3 groups. The results observed in\n                      <jats:styled-content style=\"fixed-case\">PP<\/jats:styled-content>\n                      analyses were consistent with those in\n                      <jats:styled-content style=\"fixed-case\">ITT<\/jats:styled-content>\n                      analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In a real\u2010world clinical setting in\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      hina, treatment with long\u2010acting insulin analogues was associated with better glycaemic control, as well as less hypoglycaemia and weight gain than treatment with\n                      <jats:styled-content style=\"fixed-case\">NPH<\/jats:styled-content>\n                      insulin in type 2 diabetes patients. However, the clinical relevance of these observations must be interpreted with caution.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.12920","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T07:46:51Z","timestamp":1487836011000},"page":"1116-1126","source":"Crossref","is-referenced-by-count":11,"title":["Comparative effectiveness and safety of different basal insulins in a real\u2010world setting"],"prefix":"10.1111","volume":"19","author":[{"given":"Linong","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism Peking University People's Hospital  Beijing P.R. China"},{"name":"Diabetes Research Program The George Institute for Global Health at Peking University Health Science Center  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Diabetes Research Program The George Institute for Global Health at Peking University Health Science Center  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongshan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Diabetes Research Program The George Institute for Global Health at Peking University Health Science Center  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juming","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The General Hospital of the People's Liberation Army  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Peking University First Hospital  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangfeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Diabetes Research Program The George Institute for Global Health at Peking University Health Science Center  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[{"name":"Biostatistics and Economic Evaluation Program The George Institute for Global Health at Peking University Health Science Center  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiachao","family":"Ji","sequence":"additional","affiliation":[{"name":"Biostatistics and Economic Evaluation Program The George Institute for Global Health at Peking University Health Science Center  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated Sixth People's Hospital  Shanghai P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology China\u2010Japan Friendship Hospital  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajin","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The Second Military Medical University  Shanghai P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Xiangya Second Hospital  Changsha P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Peking University First Hospital  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish K.","family":"Garg","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes University of Colorado Denver  Aurora Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyu","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The General Hospital of the People's Liberation Army  Beijing P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The Third Affiliated Hospital of Sun Yat\u2010sen University  Guangzhou P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjoy K.","family":"Paul","sequence":"additional","affiliation":[{"name":"Melbourne EpiCentre University of Melbourne  Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the ORBIT study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.33.2.97"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP13176.CS"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.10.001"},{"key":"e_1_2_6_5_1","first-page":"447","article-title":"China guideline for type 2 diabetes [in Chinese]","volume":"6","author":"Chinese Diabetes Society","year":"2013","journal-title":"Chin J Diabetes Mellitus"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-016-0120-z"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12129"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2008.00981.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.04.007"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005613.pub3"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006383.pub2"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.11.3080"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2006.08.012"},{"key":"e_1_2_6_14_1","first-page":"446","article-title":"Practice\u2010based evidence for clinical practice improvement: an alternative study design for evidence\u2010based medicine","volume":"151","author":"Horn SD","year":"2010","journal-title":"Stud Health Technol Inform"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.12"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.4313"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(10)70002-4"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1221"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01665.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-0407.2011.00137.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.862538"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2015.0054"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12886"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2480"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000325"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6207"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2117"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905479"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850321"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.08.003"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.555755"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-013-0021-3"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-39080"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0911-x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0698-4"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.07.004"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.12920","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.12920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:39:36Z","timestamp":1761860376000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.12920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/dom.12920"],"URL":"https:\/\/doi.org\/10.1111\/dom.12920","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}